Abstract

Telomerase is a cellular ribonucleoprotein, consisting of a reverse transcriptase and an endogenous RNA template, that maintains telomere length at the ends of eukaryotic chromosomes.[1] Telomeres consist of double-stranded DNA composed of tandem repeats of guanine-rich sequences (5 TTAGGG in humans) with a single-stranded 3 -end overhang necessary to ensure complete chromosomal DNA replication, while protecting the chromosome ends from fusion and degradation.[1, 2] The telomeres shorten with each round of cell division, due to incomplete lagging-strand replication, limiting the number of replicative cycles before the cell enters a state of senescence.[3] Telomere length in immortalized cells (e.g. cancer cells) is tightly regulated by the enzyme telomerase whose reverse transcriptase activity allows the addition of 5 -TTAGGG repeats to maintain telomere length through an indefinite number of cell divisions.[4] While telomerase activity is absent in human somatic cells it is detected in the majority of human tumor-derived cell lines. Consequently, telomerase has become a high-profile target for anticancer drug design.[5] The discovery that the G-rich telomeric repeats are able to assemble into novel four-stranded quadruplex structures, consisting of guanine tetrads stabilized by monovalent cations (Na and K ) (Figure 1),[6] has focused attention for structurespecific drug design. Since telomerase reverse transcriptase activity depends on a single-stranded DNA primer,[4] small molecules that bind and stabilize the folded quadruplex form of the primer are potential inhibitors of telomerase function. A number of quadruplex-specific ligands have been reported with the common feature of an extended aromatic ring system capable of interacting through extensive stacking with G-tetrads.[5] However, there has been a paucity of detailed structural data available on the drug ±DNA complexes due to intractable NMR spectra arising from extensive drug-induced line broadening.[7] The exception is a dicationic perylenetetracarboxylic diimide derivative (PIPER), which forms either a sandwich complex bound between the blunt ends of a quadruplex dimer formed from d(TTAGGG)4, or N

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.